BBVA
BCRX icon

Banco Bilbao Vizcaya Argentaria’s BioCryst Pharmaceuticals BCRX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Hold
19,249
– – ﹤0.01% 717
2025
Q4 		$148K Buy
+19,249
New +$139K ﹤0.01% 719
2020
Q3 		– Sell
-96,800
Closed -$461K – 686
2020
Q2 		$461K Hold
96,800
– – 0.01% 566
2020
Q1 		$193K Buy
96,800
+66,800
+223% +$184K 0.01% 628
2019
Q4 		$103K Buy
+30,000
New +$75.5K ﹤0.01% 704

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BCRX Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria held its BioCryst Pharmaceuticals (BCRX) position steady in Q1 2026 at 19,249 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Banco Bilbao Vizcaya Argentaria first reported a position in BCRX in Q4 2019 and has held it in 5 quarters since. The position peaked at $461K in Q2 2020. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria held 19,249 shares of BioCryst Pharmaceuticals worth $184K as of Q1 2026.
  • Banco Bilbao Vizcaya Argentaria left its BioCryst Pharmaceuticals share count unchanged in Q1 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #717 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in BioCryst Pharmaceuticals in Q4 2019 and has held it in 5 quarters since.
  • Banco Bilbao Vizcaya Argentaria's BioCryst Pharmaceuticals position peaked at $461K in Q2 2020.
  • 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.